Latest Docetaxel Stories
Protocol Amended to Provide Faster Assessment of Survival Outcomes with Reduced Trial Size BOTHELL, Wash.
CYRAMZA Now Approved in the U.S.
TOKYO and SAN FRANCISCO, April 2, 2015 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503) and Medivation, Inc.
SAN JOSE, Calif., March 24, 2015 /PRNewswire/ -- Teikoku Pharma USA (TPU) announced today that it has submitted a 505(b)(2) New Drug Application (NDA) to the U.S.
EAST SETAUKET, N.Y., March 18, 2015 /PRNewswire/ -- Lixte Biotechnology Holdings, Inc.
The Oncology Institute of Hope and Innovation announces the opening of the following clinical trial that may benefit some prostate cancer patients. Downey, CA
EAST SETAUKTET, N.Y., Feb. 25, 2015 /PRNewswire/ -- Lixte Biotechnology Holdings Inc.
AFFINITY Trial to Continue as Planned Following Completion of Interim Futility Analysis BOTHELL, Wash. and VANCOUVER, British Columbia, Jan.
- Patent Covers Taxane Prodrug Nanoparticle Delivery Technology - EWING, N.J., Dec. 18, 2014 /PRNewswire/ -- Celator Pharmaceuticals, Inc.
- Stoppage; cessation (of labor).
- A standing still or idling (of mills, factories, etc.).